NUVLHealthcareMid-Cap

Nuvalent, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Nuvalent, Inc. (NUVL), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are NUVL insiders buying or selling?

Nuvalent, Inc. insiders reported 3 open-market buys ($39.3M) and 182 sells ($624.2M) across 185 Form 4 filings — a net selling position of $585.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 8, 2026)

Total Form 4 filings
185
SEC EDGAR
Insider filers
10
Insider buys (3)
$39.3M
Insider sells (182)
$624.2M

Insider sentiment

Net selling

Net insider flow of $585.0M in net selling.

Recent NUVL insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 8, 2026James Richard PorterPresident and CEOSale30.0K$123.72$3.7M
Jul 6, 2026Darlene NociChief Development OfficerSale23.0K$123.59$2.8M
Jul 6, 2026Alexandra BalcomChief Financial OfficerSale11.4K$123.58$1.4M
Jul 1, 2026Darlene NociChief Development OfficerSale5.5K$123.51$679.3K
Jun 11, 2026Darlene NociChief Development OfficerSale20.0K$122.81$2.5M
Jun 10, 2026James Richard PorterPresident and CEOSale30.0K$88.53$2.7M
Jun 3, 2026Alexandra BalcomChief Financial OfficerSale11.4K$98.69$1.1M
Jun 1, 2026Darlene NociChief Development OfficerSale5.5K$107.80$592.9K
Jun 1, 2026Deborah Ann MillerChief Legal OfficerSale5.5K$107.84$593.1K
May 6, 2026James Richard PorterPresident and CEOSale30.0K$101.69$3.1M
May 5, 2026Alexandra BalcomChief Financial OfficerSale11.4K$99.00$1.1M
May 1, 2026Deborah Ann MillerChief Legal OfficerSale5.5K$99.22$545.7K
May 1, 2026Darlene NociChief Development OfficerSale5.5K$99.55$547.5K
Apr 13, 2026Henry E. PelishChief Scientific OfficerSale3.1K$104.48$323.2K
Apr 8, 2026James Richard PorterPresident and CEOSale30.0K$103.77$3.1M
Apr 3, 2026Alexandra BalcomChief Financial OfficerSale11.4K$105.21$1.2M
Apr 1, 2026Darlene NociChief Development OfficerSale5.5K$97.81$537.9K
Mar 30, 2026Deborah Ann MillerChief Legal OfficerSale5.5K$98.73$543.0K
Mar 26, 2026Alexandra BalcomChief Financial OfficerSale25.1K$98.15$2.5M
Mar 16, 2026Henry E. PelishChief Scientific OfficerSale35.1K$98.08$3.4M
Mar 10, 2026James Richard PorterPresident and CEOSale30.0K$98.99$3.0M
Mar 2, 2026Darlene NociChief Development OfficerSale5.5K$103.03$566.7K
Mar 2, 2026Deborah Ann MillerChief Legal OfficerSale5.5K$103.05$566.8K
Feb 2, 2026Darlene NociChief Development OfficerSale5.5K$102.08$561.4K
Jan 23, 2026Deborah Ann MillerChief Legal OfficerSale15.0K$110.15$1.7M

Showing the 25 most recent of 185 Form 4 filings for Nuvalent, Inc..

Most active NUVL insiders

  • Darlene Noci50 filings
  • Deborah Ann Miller35 filings
  • Matthew Shair29 filings
  • Alexandra Balcom22 filings
  • James Richard Porter19 filings

Ask anything about NUVL insider activity

Use Trabud's AI agent to query Nuvalent, Inc.'s Form 4 history in plain English — "Show me NUVL CEO purchases this year" or compare it against any other ticker.

Open the AI agent

NUVL insider trading FAQ

Are Nuvalent, Inc. insiders buying or selling?

Across 185 SEC Form 4 filings, Nuvalent, Inc. (NUVL) insiders reported 3 open-market purchases totaling $39.3M and 182 sales totaling $624.2M. That is a net selling position of $585.0M.

How many insiders trade NUVL stock?

10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Nuvalent, Inc.. The most recent filing was accepted on Jul 8, 2026.

Where does Trabud get NUVL insider trading data?

All NUVL insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content